5 reports

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Hospital
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Galectin Therapeutics Inc.
  • PARTNERSHIP - DEAL REPORTS
  • PARTNERSHIP

Partner ## Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement COMPANY INFORMATION: PARTNERS Company type PARTNER ##: BRIGHAM AND WOMEN' S HOSPITAL Private Galectin Therapeutics Inc.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Galectin Therapeutics Inc.
  • RECOMBINANT PROTEIN TO ACTIVATE GAL-1 FOR IMMUNOLOGY - DRUG PROFILE

Recombinant Protein to Activate Gal-## for Immunology Brigham and Women' s Hospital NA NA SB-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Mechanism Of Action SB-## Solid Biosciences LLC NA Strykagen Corp

  • Hospital
  • United States
  • Company
  • Litigation And Patent
  • Galectin Therapeutics Inc.
  • PARTNERSHIP
  • PARTNERSHIP - DEAL REPORTS

Partner ## Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement COMPANY INFORMATION: PARTNERS Company type PARTNER ##: BRIGHAM AND WOMEN' S HOSPITAL Private Galectin Therapeutics Inc.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Galectin Therapeutics Inc.
  • RECOMBINANT PROTEIN TO ACTIVATE GAL-1 FOR IMMUNOLOGY - DRUG PROFILE

GALECTIN-## (GAL-## OR LACTOSE-BINDING LECTIN ## OR ## KDA LAMININ-BINDING PROTEIN) OVERVIEW Galectin-## is a protein encoded by the LGALS## gene.

  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • Galectin Therapeutics Inc.